Table of Contents

company-logo

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California.

Spruce Biosciences Dividend Announcement

• Spruce Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Spruce Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Spruce Biosciences Dividend History

Spruce Biosciences Dividend Yield

Spruce Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Spruce Biosciences stock? Use our calculator to estimate your expected dividend yield:

Spruce Biosciences Financial Ratios

P/E ratio-0.54
PEG ratio0.18
P/B ratio0.41
ROE-62.10%
Payout ratio0.00%
Current ratio5.36
Quick ratio5.36
Cash Ratio5.06

Spruce Biosciences Dividend FAQ

Does Spruce Biosciences stock pay dividends?
Spruce Biosciences does not currently pay dividends to its shareholders.
Has Spruce Biosciences ever paid a dividend?
No, Spruce Biosciences has no a history of paying dividends to its shareholders. Spruce Biosciences is not known for its dividend payments.
Why doesn't Spruce Biosciences pay dividends?
There are several potential reasons why Spruce Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Spruce Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Spruce Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Spruce Biosciences a dividend aristocrat?
Spruce Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Spruce Biosciences a dividend king?
Spruce Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Spruce Biosciences a dividend stock?
No, Spruce Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Spruce Biosciences stocks?
To buy Spruce Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Spruce Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.